EyePoint Pharmaceuticals Shares Rise 12%
By Sabela Ojea EyePoint Pharmaceuticals shares were higher after the company earlier Monday named Jay Duker as its new chief executive. At 1:20 p.m. EDT,...
Source: marketwatch.com
Page 3 - Jay Duker News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jay Duker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jay Duker Today - Breaking & Trending Today
EyePoint Pharmaceuticals: A Puncher's Chance For Drug Success (NASDAQ:EYPT)
EyePoint Pharmaceuticals is a $200m market cap biotech focused on eye disease. Read more to see a full investment analysis of EYPT stock.
Source: seekingalpha.com
New Insight: Making Waves in the Biotech Space with Jay Duker, MD
In this episode, Veeral Sheth, MD, sits down with Jay Duker, MD for a discussion on his storied career, fostering relationships with industry, and the current technology being worked on at Eyepoint Pharmaceuticals for retinal disorders.
Source: hcplive.com
86 ophthalmology updates
Ophthalmology updates including research, partnerships, acquisitions, new hirings and more.
Source: beckersasc.com
Becker's ASC
The leading news source for ambulatory surgery center news: Becker's ASC Review magazine.
Source: beckersasc.com